🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Renato Martins

Virginia Commonwealth University

ORCID: 0000-0001-8105-4219
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Supplementary Figure from Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing”.

Supplementary Figure from Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing

10.1158/1078-0432.22488479.v1
N/A
0.125DataRank · unranked
1 citations

Holly Sandborg, Sarah M. Garrison, Henry U. Arnold, Sheng-You Liao, Justin P. Norton +9 more

Prognostic value and peripheral immunologic correlates of early FDG PET response imaging in a phase II trial of risk-adaptive chemoradiation for unresectable non-small cell lung cancer

medRxiv(2021)10.1101/2021.02.22.21251919
N/A
0.104DataRank · unranked
1 citations

Daniel S. Hippe, Hannah Thomas, Balukrishna Sasidharan, Paul D. Lampe, Christina S. Baik +12 more

Peripheral blood T-cell receptor repertoire profiling of advanced non-small cell lung cancer patients receiving PD-1/PD-L1 treatment.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21004
N/A
0DataRank · unranked
0 citations

Shin‐Heng Chiou, Viswam S. Nair, Renato Martins, Rafael Santana-Dávila, Sylvia Lee +4 more

MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity

Genes & Development(2020)10.1101/gad.340133.120
N/A
0DataRank · unranked
90 citations

Nan Wu, Huajia Zhang, Xiaoli Liu, Justin P. Norton, Yamini M. Ohol +12 more

Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors

BMC Cancer(2024)10.1186/s12885-024-13051-6
N/A
0DataRank · unranked
2 citations

Kevin Ng, Jenna Voutsinas, Brittany Barber, Zain H. Rizvi, Emily Marchiano +10 more

Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer

medRxiv(2025)10.1101/2025.03.10.25323586
N/A
0DataRank · unranked
0 citations

Christina S. Baik, Joel W. Neal, Fangdi Sun, Rafael Santana-Dávila, Sylvia Lee +13 more

Data from Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing

(2023)10.1158/1078-0432.c.6532733
N/A
0DataRank · unranked
0 citations

Holly Sandborg, Sarah M. Garrison, Henry U. Arnold, Sheng-You Liao, Justin P. Norton +9 more

Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1128
N/A
0DataRank · unranked
118 citations

Holly Sandborg, Sarah M. Garrison, Henry U. Arnold, Sheng-You Liao, Justin P. Norton +9 more